SMITH ASSET MANAGEMENT GROUP LP - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 175 filers reported holding HAEMONETICS CORP in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
SMITH ASSET MANAGEMENT GROUP LP ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q4 2018$2,379,000
-18.9%
23,780
-7.1%
0.08%
+1.2%
Q3 2018$2,933,000
+14.6%
25,600
-10.3%
0.08%
+12.2%
Q2 2018$2,559,000
+6.6%
28,540
-13.0%
0.07%
-6.3%
Q1 2018$2,400,000
-31.7%
32,810
-45.8%
0.08%
-28.2%
Q4 2017$3,514,000
+58466.7%
60,510
+32785.9%
0.11%
Q1 2014$6,000
-25.0%
1840.0%0.00%
Q4 2013$8,000
+14.3%
1840.0%0.00%
Q3 2013$7,000
-12.5%
1840.0%0.00%
Q2 2013$8,0001840.00%
Other shareholders
HAEMONETICS CORP shareholders Q2 2014
NameSharesValueWeighting ↓
Nitorum Capital, L.P. 413,122$16,608,0004.78%
Altalis Capital Management LLC 88,055$3,540,0003.97%
RUTABAGA CAPITAL MANAGEMENT LLC/MA 513,619$20,647,0003.54%
Black Creek Investment Management Inc. 1,118,613$44,968,0003.46%
HealthCor Management, L.P. 1,150,000$46,230,0002.61%
Van Berkom & Associates Inc. 1,136,971$45,706,0001.83%
AMERICAN CAPITAL MANAGEMENT INC 567,896$22,829,0001.77%
FULLER & THALER ASSET MANAGEMENT, INC. 2,062,539$82,914,0001.25%
Legato Capital Management LLC 1,336$53,707,0000.97%
HEARTLAND ADVISORS INC 351,314$14,123,0000.78%
View complete list of HAEMONETICS CORP shareholders